Categorynews

Athersys to Host Second Quarter Financial Results Call

July 20, 2020 Off By BusinessWire

CLEVELAND–(BUSINESS WIRE)–$ATHX #Athersys–Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2020 financial results at approximately 4:00 PM Eastern Time on Monday, August 10, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Members of the management team will host the call as follows:

Date	August 10, 2020
Time	4:30 p.m. (Eastern Time)
Live webcast registration	Webcast link
Phone registration	Call registration link

We encourage shareholders to listen using the webcast link above. If you would like to dial in using the phone to ask a question, please register for the conference call ahead of time using the call registration link above. Once registered, you will receive an email with the toll-free number, a direct entry passcode and a registrant ID. A reminder email will be sent the day before the live call with the above details.

A replay of the event will be available on the webcast link at www.athersys. (Read more…)com under the investors section approximately three hours after the call has ended. Shareholders may also call in for on-demand listening approximately three hours after the completion of the call until 11:59 PM Eastern Time on August 17, 2020 by dialing (800) 585-8367 or (416) 621-4642 and entering the conference code 7985439.

About Athersys

Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem^® cell therapy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.